News Image

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results

Provided By Globe Newswire

Last update: Mar 30, 2023

~ U.S. Commercial Team in Place with PEDMARK® Launch Off to Solid Start Following FDA Approval of PEDMARK® in September 2022 ~

Read more at globenewswire.com

FENNEC PHARMACEUTICALS INC

NASDAQ:FENC (11/4/2025, 8:24:14 PM)

After market: 8 0 (0%)

8

-0.13 (-1.6%)



Find more stocks in the Stock Screener

Follow ChartMill for more